Potential drug-drug interactions in patients with indication for prophylactic implantation of a cardioverter defibrillator: a cross-sectional analysis

• Egile Nagusiak: Christina Dornquast (Egilea), Mirja Dombrowski (Egilea), Markus Zabel (Egilea), Stefan N. Willich (Egilea), Thomas Reinhold (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2020-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Due to demographic transition, multimorbidity and high numbers of medicinal products, polypharmacy rates will presumably further increase. This could lead to higher risks of potentially inappropriate medications with potential drug-drug interactions (PDDI). PDDI has already been...